Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P05412 (
c-Jun
)
11,453
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Cadmium-induced cell death is associated with endoplasmic reticulum (ER) stress. We previously found that inhibition of
FBXO6
expression, which is a ubiquitin ligase involved in ER-associated protein degradation (ERAD), induces high sensitivity to cadmium in HEK293 cells. However, the precise role of
FBXO6
in ER stress remains unexplored. In this study, we investigated the role of
FBXO6
in cadmium-induced ER stress in HEK293 cells. Our results showed that the cadmium-induced increase in expression of the ER stress marker proteins, BiP and CHOP, was further enhanced by inhibiting
FBXO6
expression. Cadmium-induced
c-Jun
phosphorylation was also markedly increased by inhibition of
FBXO6
expression. However, this
c-Jun
phosphorylation was almost entirely abolished by inhibition of c-Jun N-terminal kinase 1 (JNK1) expression. The level of high cadmium sensitivity induced by inhibition of
FBXO6
expression was markedly lower in the JNK1-ablated cells than in the control cells. In addition, cadmium elevated the cellular level of ERAD substrate proteins, and this elevation was further enhanced by inhibiting
FBXO6
expression. These results suggest that
FBXO6
might inhibit cadmium-induced ER stress by functioning as a ubiquitin ligase in the ERAD system, thereby attenuating the cell death induced by subsequent JNK1 activation.
...
PMID:FBXO6 attenuates cadmium toxicity in HEK293 cells by inhibiting ER stress and JNK activation. 2537 77